NHS National Pharmaceuticals Transition 2021_3
The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-02b7a632014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
59
32 SME
Lots
7
59 awarded
Published
04 Nov 2021
Description
NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633
Scope
- Reference
- CM/PHG/21/5633
- Commercial tool
- Standalone contract
- Contract dates
- 30 Sept 2021 to 31 May 2024
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 59 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
Lots · 7 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Hospital Only Products – CESW region | — | cancelled |
| 2 | Hospital Only Products – LSNE region | — | cancelled |
| 3 | Hospital Only Products – NWLN region | — | cancelled |
| 4 | Oral (plus non-parenteral) products: All regions | — | cancelled |
| 6 | Transition Products – LSNE region | — | cancelled |